ARCALYST

Indicated For

Recurrent pericarditis, Cryopyrin-Associated Periodic Syndromes (CAPS), Familial Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells Syndrome (MWS)

About This Medication

# Kinikska Patient Assistance Program Patient Guide: How to Get ARCALYST at Low or No Cost ## About ARCALYST (rilonacept) ARCALYST is a prescription medication used to treat certain inflammatory conditions. If you've been prescribed ARCALYST but are concerned about the cost, the Kinikska Patient Assistance Program may be able to help you access this medication at no cost or at a significantly reduced price. ## Who Qualifies for This Program? The Kinikska Patient Assistance Program is designed for patients who: - Are uninsured or underinsured - Do not have adequate insurance coverage for ARCALYST - Meet certain financial eligibility requirements - Are residents of the United States or Puerto Rico **Important:** This program is **not available** if you have Medicare, Medicaid, or other government insurance. If you have government insurance, your healthcare provider can help you explore other coverage options. ## Income Eligibility The program uses a needs-based assessment to determine eligibility. While specific income thresholds are not publicly listed, the program evaluates your financial situation to determine if you qualify for assistance. During the enrollment process, a Patient Access Lead will work with you to assess your eligibility and discuss your financial circumstances confidentially. ## Insurance Requirements To qualify for the Kinikska Patient Assistance Program: - You must be uninsured or underinsured - You cannot have Medicare, Medicaid, or other government insurance - You must meet the program's financial eligibility criteria - You must agree to the program's terms and conditions If you have commercial insurance but are struggling with copays or coinsurance, you may be eligible for the **Kinikska Copay Assistance Program** instead, which is a separate program designed to help reduce your out-of-pocket costs. ## How to Apply: Step-by-Step ### Step 1: Get Your Prescription Your healthcare provider must prescribe ARCALYST and decide to enroll you in the Kinikska OneConnect™ program, which manages the patient assistance programs. ### Step 2: Gather Required Documents Before applying, collect the following: - A copy of your medical insurance card (front and back) - A copy of your prescription insurance card (front and back) - Your completed enrollment form (provided by your healthcare provider) - Any additional documentation requested by the program ### Step 3: Complete the Enrollment Form Your healthcare provider will complete the enrollment form with your information. You will need to: - Read and sign the Patient Consent Information form - Provide accurate demographic and financial information - Authorize the program to verify your insurance and assess your eligibility If you cannot sign the form at submission, a Patient Access Lead can help you sign electronically after enrollment begins. ### Step 4: Submit Your Application Your healthcare provider will fax the completed enrollment form along with copies of your insurance cards to: **Fax: 1-781-609-7826** Make sure all required fields are completed, as incomplete applications may delay the start of your treatment. ### Step 5: Await Contact from Your Patient Access Lead After your application is received, a dedicated Patient Access Lead from the Kinikska OneConnect™ program will contact you to: - Explain the program services and next steps - Verify your insurance coverage - Discuss your eligibility for financial assistance - Answer any questions you have about the program ## Timeline and Medication Delivery **Processing Time:** The program does not publish a specific processing timeline, but the Patient Access Lead will contact you promptly after your application is submitted to discuss your eligibility status. **Medication Delivery:** Once you are approved, your ARCALYST medication will be shipped directly to you or your healthcare provider. The Patient Access Lead will coordinate the delivery details with you. **Quick Start Option:** If you are experiencing delays in insurance authorization and need to begin treatment immediately, you may qualify for the Kinikska Quick Start Program, which provides up to 60 days of free ARCALYST while you wait for insurance approval. ## What Happens If Your Application Is Denied? If you are not approved for the patient assistance program, the Patient Access Lead will: - Explain the reason for the denial - Discuss alternative financial assistance options - Help you explore other sources of funding or support - Work with your healthcare provider to identify other potential solutions You may also be eligible for other Kinikska programs, such as the Copay Assistance Program if you have commercial insurance. ## Reauthorization and Refills The Kinikska Patient Assistance Program requires reauthorization. This means you will need to: - Maintain contact with your Patient Access Lead - Provide updated information as requested - Reapply or reauthorize your assistance periodically Your Patient Access Lead will help coordinate refills on time and guide you through any reauthorization requirements to ensure you have uninterrupted access to your medication. ## Getting Help If you have questions about the program or need assistance with your application, contact the Kinikska OneConnect™ program: **Phone:** 1-833-KINIKSA (1-833-546-4572), Option 1 **Hours:** Monday–Friday, 8 AM–8 PM ET Your dedicated Patient Access Lead is available to answer questions about insurance coverage, prior authorization, cost-saving options, and refill coordination. ## Important Disclaimer This guide provides general information about the Kinikska Patient Assistance Program for ARCALYST. Program eligibility, benefits, and terms are subject to change. For the most current and complete information about eligibility requirements, please visit kiniksapolicies.com/pap or contact the Kinikska OneConnect™ program directly. This guide is not a guarantee of program enrollment or medication provision. Your healthcare provider and the Kinikska OneConnect™ program will make final determinations regarding your eligibility and assistance.

Program information last verified: March 30, 2026